Literature DB >> 29749285

Thoracic intervention & surgery to cure lung cancer: margin not lobe is the new gold standard.

David Waller1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29749285      PMCID: PMC6512168          DOI: 10.1177/0141076818775078

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  20 in total

1.  Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.

Authors:  Matthew J Schuchert; Brian L Pettiford; Samuel Keeley; Thomas A D'Amato; Arman Kilic; John Close; Arjun Pennathur; Ricardo Santos; Hiran C Fernando; James R Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

2.  NOMENCLATURE of broncho-pulmonary anatomy; an international nomenclature accepted by the Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1950-09       Impact factor: 9.139

3.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

4.  Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.

Authors:  Rodney J Landreneau; Daniel P Normolle; Neil A Christie; Omar Awais; Joseph J Wizorek; Ghulam Abbas; Arjun Pennathur; Manisha Shende; Benny Weksler; James D Luketich; Matthew J Schuchert
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

5.  Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer.

Authors:  Cardinale B Smith; Scott J Swanson; Grace Mhango; Juan P Wisnivesky
Journal:  J Thorac Oncol       Date:  2013-01       Impact factor: 15.609

Review 6.  Complete resection in lung cancer surgery: proposed definition.

Authors:  Ramón Rami-Porta; Christian Wittekind; Peter Goldstraw
Journal:  Lung Cancer       Date:  2005-07       Impact factor: 5.705

7.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

8.  Indocyanine green fluorescence-navigated thoracoscopic anatomical segmentectomy.

Authors:  Mingyon Mun; Sakae Okumura; Masayuki Nakao; Yosuke Matsuura; Ken Nakagawa
Journal:  J Vis Surg       Date:  2017-06-07

9.  Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.

Authors:  Rajwanth R Veluswamy; Nicole Ezer; Grace Mhango; Emily Goodman; Marcelo Bonomi; Alfred I Neugut; Scott Swanson; Charles A Powell; Mary B Beasley; Juan P Wisnivesky
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

10.  Margin and local recurrence after sublobar resection of non-small cell lung cancer.

Authors:  Amgad El-Sherif; Hiran C Fernando; Ricardo Santos; Brian Pettiford; James D Luketich; John M Close; Rodney J Landreneau
Journal:  Ann Surg Oncol       Date:  2007-05-16       Impact factor: 5.344

View more
  3 in total

1.  NICE values, essential values.

Authors:  Kamran Abbasi
Journal:  J R Soc Med       Date:  2019-05       Impact factor: 5.344

2.  Thoracic surgery for lung cancer: current practice and future directions.

Authors:  Aman Coonar; Giuseppe Aresu; Adam Peryt; Jason Ali
Journal:  J R Soc Med       Date:  2019-01-30       Impact factor: 5.344

3.  Thoracic intervention and surgery to cure lung cancer.

Authors:  Tom Treasure
Journal:  J R Soc Med       Date:  2018-05-11       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.